A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer

Empreu sempre aquest identificador per citar o enllaçar aquest ítem http://hdl.handle.net/10045/77775
Información del item - Informació de l'item - Item information
Títol: A scoring system to predict 5‐year mortality in patients diagnosed with laryngeal glottic cancer
Autors: Jover-Esplá, Ana Gabriela | Palazón Bru, Antonio | Folgado-de la Rosa, David M. | Juan Herrero, Joaquín de | Gil Guillén, Vicente
Grups d'investigació o GITE: Biotecnología
Centre, Departament o Servei: Universidad de Alicante. Departamento de Biotecnología
Paraules clau: Glottis | Laryngeal neoplasms | Mobile applications | Models | Statistical | Mortality
Àrees de coneixement: Biología Celular
Data de publicació: de juliol-2018
Editor: John Wiley & Sons
Citació bibliogràfica: European Journal of Cancer Care. 2018, 27(4): e12860. doi:10.1111/ecc.12860
Resum: Only one prognostic model for laryngeal cancer has been published, but it has not been properly validated and is only applicable to patients treated with radiotherapy. Consequently, we constructed, internally validated and implemented in an App (Android), a predictive model of 5‐year mortality in patients with glottic cancer in a cohort study of 189 patients with glottic cancer in 2004–2016 in Spain. The main variable was time‐to‐death. Secondary variables were age, gender, TNM, stage, smoking, alcohol consumption, histology and treatment. A scoring system to predict mortality at 5 years was constructed, validated internally by bootstrapping and then integrated into an Android app. In all, 70 patients died (37.0%, 76 deaths per 1,000 patient‐years). The predictive model had the following prognostic factors: larger tumour size, greater degree of lymph node metastasis, higher stage, smoking and alcohol consumption. The internal validation of the model through bootstrapping was satisfactory. In conclusion, a points system to predict mortality at 5 years in patients with glottic cancer has been constructed, internally validated and integrated into an Android application. External validation is suggested to make available a quick and simple tool to establish the prognosis for these patients.
URI: http://hdl.handle.net/10045/77775
ISSN: 0961-5423 (Print) | 1365-2354 (Online)
DOI: 10.1111/ecc.12860
Idioma: eng
Tipus: info:eu-repo/semantics/article
Drets: © 2018 John Wiley & Sons Ltd
Revisió científica: si
Versió de l'editor: https://doi.org/10.1111/ecc.12860
Apareix a la col·lecció: INV - GIDBT - Artículos de Revistas

Arxius per aquest ítem:
Arxius per aquest ítem:
Arxiu Descripció Tamany Format  
Thumbnail2018_Jover-Espla_etal_EurJCancerCare_final.pdfVersión final (acceso restringido)458,95 kBAdobe PDFObrir     Sol·licitar una còpia


Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.